Zobrazeno 1 - 10
of 328
pro vyhledávání: '"Maarten Joost IJzerman"'
Autor:
Luiza R Grazziotin, Susanne M. Benseler, Michelle M.A. Kip, Inge van den Berg, Nico M Wulffraat, Sytze de Roock, Gillian Currie, Marinka Twilt, Deborah A. Marshall, Maarten Joost IJzerman, Sebastiaan J. Vastert, Joost F. Swart, Rae S. M. Yeung
Publikováno v:
Arthritis Care and Research, 74(10), 1585-1592. Wiley
Arthritis Care and Research. John Wiley & Sons Inc.
Arthritis Care and Research. John Wiley & Sons Inc.
Objective: The aim of this study was to quantify costs of hospital-associated care for juvenile idiopathic arthritis (JIA), provide insights in patient-level variation in costs, and investigate costs over time from the moment of JIA diagnosis. Result
Autor:
Maria A. Sierra, Jack C. W. Wheeler, Kate E. Jones, Alison H. Trainer, Maarten Joost IJzerman, Louise Keogh, Lisa Devereux
Publikováno v:
Genetics in Medicine, 24(1), 146-156. Lippincott Williams & Wilkins
Purpose: Risk-stratified screening has potential to improve the cost effectiveness of national breast cancer screening programs. This study aimed to inform a socially acceptable and equitable implementation framework by determining what influences a
Autor:
Amanda Pereira-Salgado, Shankar Siva, Anis A. Hamid, Koen Degeling, Niall M. Corcoran, Maarten Joost IJzerman
Publikováno v:
Value in Health. 24:1737-1745
Objectives To estimate the lifetime health and economic outcomes of selecting active surveillance (AS), radical prostatectomy (RP), or radiation therapy (RT) as initial management for low- or favorable-risk localized prostate cancer. Methods A discre
Autor:
Rae S. M. Yeung, Joost F Swart, Heinrike Schmeling, Deborah A. Marshall, Gillian Currie, Nadia Luca, Sebastiaan J. Vastert, Maarten Joost IJzerman, Marinka Twilt, Nicole Johnson, Susanne M. Benseler, Ucan Cure consortia Ucan Can-Du, Michelle M.A. Kip, Nico M Wulffraat, Hendrik Koffijberg, Luiza R Grazziotin, Paivi Miettunen
Publikováno v:
Rheumatology and Therapy, 8(3), 1303-1322. Adis
Rheumatology and Therapy
Rheumatology and Therapy, 8(3), 1303-1322. Adis International Ltd
Rheumatology and Therapy
Rheumatology and Therapy, 8(3), 1303-1322. Adis International Ltd
Introduction Juvenile idiopathic arthritis (JIA) is a chronic rheumatic disease, whose multifaceted care path can lead to significant expenditure for the healthcare system. We aim to assess the real-world healthcare resource use (HCRU) and associated
Autor:
Meinir Krishnasamy, Danny Rischin, Gregory B Crawford, Brian Le, Jennifer Philip, Sue-Anne McLachlan, Roslyn Le Gautier, Anna Collins, Vijaya Sundararajan, Geoff Mitchell, Maarten Joost IJzerman, Anna K. Nowak, Tanara Vieira Sousa, Robyn Hudson, Nicole Rankin
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Health Services Research
BMC Health Services Research
Background Current international consensus is that ‘early’ referral to palliative care services improves cancer patient and family carer outcomes. In practice, however, these referrals are not routine. An approach which directly addresses identif
Autor:
Elly Lynch, Melissa Martyn, Clara Gaff, Koen Degeling, Martin Vu, Maarten Joost IJzerman, Belinda Chong
Publikováno v:
Genetics in Medicine, 23(4), 606-613. Lippincott Williams & Wilkins
Purpose: To evaluate the resource implications of different delivery models for the provision of additional findings (AF) in genomics from a health-care purchaser perspective. Methods: Data from the Additional Findings study were used to develop and
Autor:
Hendrik Koffijberg, Valesca P. Retèl, Michiel van de Ven, Wim H. van Harten, Egbert F. Smit, Kim Monkhorst, Maarten Joost IJzerman
Publikováno v:
Journal of Molecular Diagnostics, 23(4), 484-494. Elsevier Inc.
Journal of Molecular Diagnostics, 23(4), 484-494. Association of Molecular Pathology
The Journal of Molecular Diagnostics, 23(4), 484-494. ELSEVIER SCIENCE INC
Journal of Molecular Diagnostics, 23(4), 484-494. Association of Molecular Pathology
The Journal of Molecular Diagnostics, 23(4), 484-494. ELSEVIER SCIENCE INC
The continued introduction of biomarkers and innovative testing methods makes already complex diagnosis in patients with stage IV nonesmall-cell lung cancer (NSCLC) even more complex. This study primarily analyzed variations in biomarker testing in c
Autor:
Hendrik Koffijberg, Marjolein J.E. Greuter, Veerle M.H. Coupé, Koen Degeling, Maarten Joost IJzerman
Publikováno v:
Value in Health, 24(2), 206-215. Elsevier Ltd.
Value in Health, 24(2), 206-215. Elsevier Limited
Koffijberg, H, Degeling, K, IJzerman, M J, Coupé, V M H & Greuter, M J E 2021, ' Using Metamodeling to Identify the Optimal Strategy for Colorectal Cancer Screening ', Value in Health, vol. 24, no. 2, pp. 206-215 . https://doi.org/10.1016/j.jval.2020.08.2099
Value in health, 24(2), 206-215. Elsevier
Value in Health, 24(2), 206-215. Elsevier Limited
Koffijberg, H, Degeling, K, IJzerman, M J, Coupé, V M H & Greuter, M J E 2021, ' Using Metamodeling to Identify the Optimal Strategy for Colorectal Cancer Screening ', Value in Health, vol. 24, no. 2, pp. 206-215 . https://doi.org/10.1016/j.jval.2020.08.2099
Value in health, 24(2), 206-215. Elsevier
Objectives: Metamodeling can address computational challenges within decision-analytic modeling studies evaluating many strategies. This article illustrates the value of metamodeling for evaluating colorectal cancer screening strategies while account
Publikováno v:
PharmacoEconomics Open
Objective Point-of-care testing (POCT) has become an essential diagnostic technology for optimal patient care. Its implementation, however, still falls behind. This paper reviews the available evidence on the health economic impact of introducing POC
Autor:
Gillian Currie, Annet van Royen-Kerkhof, Susanne M. Benseler, Nico M Wulffraat, Sebastiaan J. Vastert, Deborah A. Marshall, Marinka Twilt, Michelle M.A. Kip, Joost F. Swart, Maarten Joost IJzerman, Luiza R Grazziotin, Sytze de Roock, Rae S. M. Yeung, Maud Annemarie Schreijer
Publikováno v:
Expert Review of Pharmacoeconomics and Outcomes Research, 21(5), 975-984. Taylor & Francis
Expert Review of Pharmacoeconomics and Outcomes Research, 21(5), 975-984. Taylor & Francis Ltd
Expert Review of Pharmacoeconomics and Outcomes Research, 21(5), 975-984. Taylor & Francis Ltd
Background: This study aims to quantify medication costs in juvenile idiopathic arthritis (JIA), based on subtype. Research design and methods: This study is a single-center, retrospective analysis of prospective data from electronic medical records